| Colbe Ingels, FNP-BC | |
|
2520 Valley Dr, Point Pleasant, WV 25550-2031 | |
| (304) 675-4340 | |
| Not Available |
| Full Name | Colbe Ingels |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 2520 Valley Dr, Point Pleasant, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780109207 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | APRN79848-FNP-BC (West Virginia) | Primary |
| Entity Name | Point Pleasant Physician Billing Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798898 PECOS PAC ID: 3375538184 Enrollment ID: O20040419001780 |
News Archive
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
Chlamydia trachomatis is a human pathogen that is the leading cause of bacterial sexually transmitted disease worldwide with more than 90 million new cases of genital infections occurring each year. About 70 percent of women infected with Chlamydia remain asymptomatic and these bacteria can establish chronic infections for months, or even years. Even when it causes no symptoms, Chlamydia can damage a woman's reproductive organs. In addition, standard antibacterial drugs are proving increasingly ineffective in complete eradication, as Chlamydia goes in to persistent mode, leading to asymptomatic chronic infection.
The Department of Health today announced the Centers for Disease Control and Prevention, or CDC, has allocated more than 566,000 doses of H1N1 vaccine to Pennsylvania. While delays in vaccine production have occurred, the department is placing orders as soon as vaccine is allocated to ensure it reaches Pennsylvania residents as quickly as possible.
Researchers at the University of Sheffield have developed innovative technology which illuminates a person's lungs and helps clinicians identify if they are functioning correctly. The new technology could result in earlier diagnosis of emphysema and smoking related damage, as well as other lung conditions and diseases.
QIAGEN N.V. today announced that the U.S. Food and Drug Administration (FDA) has granted two 510(k) clearances for its real-time PCR (polymerase chain reaction) instrument Rotor-Gene Q MDx and a compatible test for the detection of Influenza A/B, the artus Infl A/B RG RT-PCR Kit, for in vitro diagnostic use.
› Verified 1 days ago
| Entity Name | James R Toothman Do Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528627957 PECOS PAC ID: 0749515575 Enrollment ID: O20210803002358 |
News Archive
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
Chlamydia trachomatis is a human pathogen that is the leading cause of bacterial sexually transmitted disease worldwide with more than 90 million new cases of genital infections occurring each year. About 70 percent of women infected with Chlamydia remain asymptomatic and these bacteria can establish chronic infections for months, or even years. Even when it causes no symptoms, Chlamydia can damage a woman's reproductive organs. In addition, standard antibacterial drugs are proving increasingly ineffective in complete eradication, as Chlamydia goes in to persistent mode, leading to asymptomatic chronic infection.
The Department of Health today announced the Centers for Disease Control and Prevention, or CDC, has allocated more than 566,000 doses of H1N1 vaccine to Pennsylvania. While delays in vaccine production have occurred, the department is placing orders as soon as vaccine is allocated to ensure it reaches Pennsylvania residents as quickly as possible.
Researchers at the University of Sheffield have developed innovative technology which illuminates a person's lungs and helps clinicians identify if they are functioning correctly. The new technology could result in earlier diagnosis of emphysema and smoking related damage, as well as other lung conditions and diseases.
QIAGEN N.V. today announced that the U.S. Food and Drug Administration (FDA) has granted two 510(k) clearances for its real-time PCR (polymerase chain reaction) instrument Rotor-Gene Q MDx and a compatible test for the detection of Influenza A/B, the artus Infl A/B RG RT-PCR Kit, for in vitro diagnostic use.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Colbe Ingels, FNP-BC 2520 Valley Dr, Point Pleasant, WV 25550-2031 Ph: (304) 675-4340 | Colbe Ingels, FNP-BC 2520 Valley Dr, Point Pleasant, WV 25550-2031 Ph: (304) 675-4340 |
News Archive
ZymoGenetics, Inc. announced that final progression-free survival results will be presented from a Phase 2 clinical trial in patients with Stage 4 metastatic melanoma at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on June 5, 2010 in an oral presentation. The open-label multi-center clinical trial evaluated 3 dose regimens of Interleukin 21 (IL-21) in 40 patients with no prior systemic therapy for metastatic melanoma.
Chlamydia trachomatis is a human pathogen that is the leading cause of bacterial sexually transmitted disease worldwide with more than 90 million new cases of genital infections occurring each year. About 70 percent of women infected with Chlamydia remain asymptomatic and these bacteria can establish chronic infections for months, or even years. Even when it causes no symptoms, Chlamydia can damage a woman's reproductive organs. In addition, standard antibacterial drugs are proving increasingly ineffective in complete eradication, as Chlamydia goes in to persistent mode, leading to asymptomatic chronic infection.
The Department of Health today announced the Centers for Disease Control and Prevention, or CDC, has allocated more than 566,000 doses of H1N1 vaccine to Pennsylvania. While delays in vaccine production have occurred, the department is placing orders as soon as vaccine is allocated to ensure it reaches Pennsylvania residents as quickly as possible.
Researchers at the University of Sheffield have developed innovative technology which illuminates a person's lungs and helps clinicians identify if they are functioning correctly. The new technology could result in earlier diagnosis of emphysema and smoking related damage, as well as other lung conditions and diseases.
QIAGEN N.V. today announced that the U.S. Food and Drug Administration (FDA) has granted two 510(k) clearances for its real-time PCR (polymerase chain reaction) instrument Rotor-Gene Q MDx and a compatible test for the detection of Influenza A/B, the artus Infl A/B RG RT-PCR Kit, for in vitro diagnostic use.
› Verified 1 days ago
Rebecca Lowery, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2520 Valley Dr, Suite 112, Point Pleasant, WV 25550 Phone: 304-675-1244 | |
Megan Michelle Wamsley, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2520 Valley Dr, Point Pleasant, WV 25550 Phone: 304-675-4340 | |
Ms. Diana Lynn Riddle, BC-FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 216 5th St, Point Pleasant, WV 25550 Phone: 304-675-3050 Fax: 304-675-4801 | |
Brooke Briana Frost, APRN, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2520 Valley Dr, Point Pleasant, WV 25550 Phone: 304-675-4340 | |
Mrs. Sarah B Mechelle Sprouse, MSN, APRN, FNP-BC Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 2500 Jefferson Ave, Point Pleasant, WV 25550 Phone: 304-675-2230 Fax: 304-675-2234 | |
Bonni Lyn Roach, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3471 Ohio River Rd, Point Pleasant, WV 25550 Phone: 304-857-6494 | |
Ms. Melissa Jean Taylor, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2520 Valley Dr, Suite 11, Point Pleasant, WV 25550 Phone: 304-675-2551 Fax: 304-675-6081 |